Search results for "hepatocyte"

showing 10 items of 369 documents

Hepatocyte-like cells differentiated from Wharton's jelly mesenchymal stem cells: functional characterization and expression of immunomodulatory mole…

2014

Settore BIO/16 - Anatomia UmanaMesenchymal cells hepatocyte WJ-MSC immonumodulatory activity.
researchProduct

Wharton’s jelly mesenchymal stem cells differrentiation towards hepatocyte-like cells: in vitro evidences

2012

Settore BIO/16 - Anatomia UmanaWharton’s jelly mesenchymal stem cells differrentiationhepatocyte-like cells
researchProduct

Wharton's jelly mesenchymal stem cells differentiation towards hepatocyte-like cells: functional characterization and expression of immunomodulatory …

2014

Settore BIO/16 - Anatomia Umanahepatocyte-like HLA-E WJ-MSC wharton's jelly
researchProduct

Non-classical type I HLAs and B7 costimulators revisited: analysis of expression and immunomodulatory role in undifferentiated and differentiated MSC…

2011

Introduction. Wharton’s jelly (WJ), the main constituent of umbilical cord, emerged as a reliable and uncontroversial source of mesenchymal stem cells (MSC). WJ-MSC show unique ability in crossing lineage borders, therefore being capable to trans-ifferentiate towards mature cytotypes derived from the three germ layers. As other fetal-associated cells, WJ-MSC express several immunomodulatory molecules, essential during the initial phases of human development and for the processes linked to the tolerance of the mother to the semiallogeneic embryo. Very few data are present in literature on the maintenance of the immune privilege of the naïve cells after performing differentiation. Our previou…

Settore BIO/16 - Anatomia Umanamesenchymal stem cells umbilical cord Wharton's jelly immune modulation hepatocyte differentiation
researchProduct

GALACTOSE-DECORATED POLYMERIC CARRIERS FOR HEPATOCYTE-SELECTIVE DRUG TARGETING

2015

In this paper, the current available strategies to realize galactose-decorated nanostructured polymeric systems are summarized. These carriers are designed in order to obtain targeted drug delivery to hepatocytes via galactose (GAL) moieties, i.e., for the treatment of viral hepatitis or liver cancer that are the greater causes of global disability and mortality. Usually, the main followed strategy to obtain galactosylated polymeric carriers is to use galactosylated copolymers. The chemical modifications of preformed polymers with sugar-containing reagents is followed for obtaining lactosaminated human albumin, galactosylated phospholipid-polyaminoacid and polylactide (PLA)- polyaminoacid c…

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoAsialoglycoprotein receptor (ASGP-R) carboxymethyl chitosan (CMC) galactose (GAL) hepatocytes lactosaminated albumin liver targeting poly(ε-caprolactone) (PCL) polyamidoamine (PAMAM) dendrimers polycarbonates polylactide (PLA) xyloglucan αβ-poly(N-2-hydroxyethyl)-DLaspartamide (PHEA).
researchProduct

Topological Information, Flux Balance Analysis, and Extreme Pathways Extraction for Metabolic Networks Behaviour Investigation

2011

In recent years biological processes modeling and simulation have become two key issues in analyzing complex cellular systems. Information about metabolic networks is often incomplete, since a large portion of available data is ignored by its probabilistic nature. The main objective of this work is to investigate metabolic networks behavior in terms of their fault tolerance capabilities as random removal of network nodes and high-connectivity-degree node deletion aimed at compromising or modifying network activity. This paper proposes a software framework, namely CEllDataLaB, containing three tasks to perform the structural and functional analysis: topological analysis, flux balance analysi…

Settore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniMetabolic networks structural analysis functional analysis hepatocyte metabolism
researchProduct

AP-1 Transcription Factor Serves as a Molecular Switch between Chlamydia pneumoniae Replication and Persistence

2015

ABSTRACT Chlamydia pneumoniae is a Gram-negative bacterium that causes acute or chronic respiratory infections. As obligate intracellular pathogens, chlamydiae efficiently manipulate host cell processes to ensure their intracellular development. Here we focused on the interaction of chlamydiae with the host cell transcription factor activator protein 1 (AP-1) and its consequence on chlamydial development. During Chlamydia pneumoniae infection, the expression and activity of AP-1 family proteins c-Jun, c-Fos, and ATF-2 were regulated in a time- and dose-dependent manner. We observed that the c-Jun protein and its phosphorylation level significantly increased during C. pneumoniae development.…

Small interfering RNAGene knockdownCellular Microbiology: Pathogen-Host Cell Molecular InteractionsTranscription GeneticImmunologyChlamydiaeGene Expression Regulation BacterialHep G2 CellsChlamydophila pneumoniaeBiologybiology.organism_classificationMicrobiologyBacterial LoadMicrobiologyTranscription Factor AP-1AP-1 transcription factorInfectious DiseasesTranscription (biology)Host-Pathogen InteractionsHepatocytesHumansPhosphorylationParasitologyTranscription factorIntracellularInfection and Immunity
researchProduct

Neue Therapieoption für akute hepatische Porphyrien

2021

Was ist neu? Therapie mit Givosiran Givosiran ist ein kleines synthetisches doppelsträngiges siRNA-Fragment mit 20 Basenpaaren Länge. Eine prospektive, randomisierte multizentrische Studie (Envision) zeigte erstmalig die klinische Wirksamkeit von monatlich subkutan applizierten synthetischen RNA-Molekülen („small interfering“ RNA, siRNA) zur Prävention von Attacken bei akuten hepatischen Porphyrien (AHP) 2. Die Koppelung von siRNA-Molekülen an N-Acetyl-Galaktosamin (GalNAc) und die hierdurch leberspezifische Aufnahme durch den Asialoglykoprotein-Rezeptor auf Hepatozyten sind ein Meilenstein in der Hepatologie. Dies führt zu einer hochselektiven Inhibition der Translation der bei AHP überexp…

Small interfering RNAmedicine.medical_specialtybusiness.industryRenal functionGeneral MedicinePharmacologyHepatologymedicine.diseaseSubcutaneous injectionmedicine.anatomical_structurePorphyriaHepatocyteInternal medicinemedicineAsialoglycoprotein receptorClinical efficacybusinessDMW - Deutsche Medizinische Wochenschrift
researchProduct

Dependency of the in vitro stabilization of differentiated functions in liver parenchymal cells on the type of cell line used for co-culture.

1992

The differentiation status in cultures of primary rat liver parenchymal cells was determined by measuring the activities of various xenobiotic metabolizing enzymes. Most enzyme activities dropped rather rapidly in monocultures of parenchymal cells. The protein content and the activities of cytosolic epoxide hydrolase, glutathione S-transferase, and alpha-naphthol UDP-glucuronosyl transferase were, however, well stabilized in 7-day-old co-cultures of parenchymal cells with two different lines of rat liver nonparenchymal epithelial cells (NEC1 and NEC2). Phenol sulfotransferase and microsomal epoxide hydrolase activity were reduced in this coculture system after 7 days to about 30 and 20% of …

SulfotransferaseClinical BiochemistryBiologyCell LineXenobioticschemistry.chemical_compoundmedicineAnimalsGlutathione transferase activityGlucuronosyltransferaseEpoxide hydrolaseCells CulturedGlutathione TransferaseEpoxide HydrolasesProteinsCell DifferentiationCell BiologyGeneral MedicineGlutathioneArylsulfotransferaseRatsmedicine.anatomical_structurechemistryBiochemistryLiverCell cultureMicrosomal epoxide hydrolaseHepatocyteStem cellDevelopmental BiologyIn vitro cellulardevelopmental biology : journal of the Tissue Culture Association
researchProduct

Solubilized liver extracellular matrix maintains primary rat hepatocyte phenotype in-vitro.

2015

Whole organ engineering and cell-based regenerative medicine approaches are being investigated as potential therapeutic options for end-stage liver failure. However, a major challenge of these strategies is the loss of hepatic specific function after hepatocytes are removed from their native microenvironment. The objective of the present study was to determine if solubilized liver extracellular matrix (ECM), when used as a media supplement, can better maintain hepatocyte phenotype compared to type I collagen alone or solubilized ECM harvested from a non-liver tissue source. Liver extracellular matrix (LECM) from four different species was isolated via liver tissue decellularization, solubil…

Swineextracellular matrixCell Culture TechniquesBiomedical EngineeringCeramics and CompositeliverCollagen Type IRats Sprague-DawleyBiomaterialsDogsDogAnimalsHumansHepatocytebiologic scaffoldCells CulturedAnimalMetals and AlloysHydrogelsBiomaterialRatsCulture Mediahepatocyte cultureHydrogelSolubilitytissue engineeringHepatocytesCeramics and CompositesRat2506RheologyCell Culture TechniqueHumanJournal of biomedical materials research. Part A
researchProduct